AlphAIAlphAI — Financial news for AI agents
nai500.comOCT 72 min read$OPCH

Option Care Health Receives $5.8 Billion Acquisition Offer, Stock Price Soars 33% in a Single Day

Option Care Health (OPCH) agreed to a $5.8B acquisition by McKesson (MCK) and CD&R at $32.05 per share, a 37% premium. Stock surged 33% on the news. Deal expected to close in 2027, with CD&R holding 51% and McKesson 49%. Option Care will operate independently, led by current management. Despite the gain, shares remain 15% below their 2024 high.

Original reporting
nai500.com
Published Oct 7, 2026, 7:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 8:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Option Care Health Receives $5.8 Billion Acquisition Offer, Stock Price Soars 33% in a Single Day — source image
Source · nai500.com
Decision brief

The 30-second read

$OPCHBullishHigh
01

Why it matters

The acquisition creates the largest independent home‑infusion provider, potentially reshaping the market.

02

Market read

A $5.8 billion M&A deal with a 33% stock surge signals strong market impact for both parties and the broader healthcare services sector.

03

What to watch

Regulatory approval timelines and potential future stake buy‑out by McKesson could affect deal economics.

Relevance 9/10Novelty 9/10Timing: today

Background

Option Care Health provides home and alternate‑site infusion services; McKesson is a major pharmaceutical distributor.

Company-level read

Ticker impact

$OPCHBullishHigh confidence
Context

Option Care Health announced a $5.8 billion acquisition by McKesson and CD&R at $32.05 per share, triggering a 33% stock surge.

Expected impact

likely upward pressure as market prices in the acquisition premium, with potential short‑term consolidation after the surge

Evidence & confidence

The announced price represents a 37% premium and the stock already jumped 33% on the news, indicating strong buyer interest.

$MCKBullishMedium confidence
Context

McKesson is a co‑acquirer of Option Care Health in the $5.8 billion transaction, taking a 49% stake.

Expected impact

moderate upside as the deal adds strategic assets and revenue streams

Evidence & confidence

The transaction broadens McKesson's service portfolio; market typically rewards strategic acquisitions with incremental share price gains.

Market effects

Sector

Consolidation in home‑infusion and alternate‑site care may pressure peers' valuations.

Regional

U.S. healthcare services sector sees increased M&A activity signals.

Global

Large‑scale healthcare deal highlights continued private‑equity involvement in U.S. health services.

Counterpoint

What could challenge this read

The premium may be excessive; integration risks could weigh on long‑term performance.

Key entities

  • Company
    Option Care Health

    Largest independent provider of home and alternate‑site infusion services in the U.S.

  • Company
    McKesson Corporation

    Pharmaceutical distribution and health services company acquiring a 49% stake.

Read at source← All news

Also covered by

3 outlets

Related articles

OCT 7
$MCKHighAI 9/10

McKesson, private equity firm buy home infusion company, Option Care Health

McKesson Corporation and private equity firm Clayton Dubilier & Rice (CD&R) agreed to acquire Option Care Health, a home infusion company, for $5.8 billion. McKesson will invest $1.4 billion for a 49% stake, with CD&R taking 51%. The deal values Option Care Health at $32.05 per share, a 36% premium over Monday's closing price. Once completed, Option Care Health will become private and delist from Nasdaq.

managedhealthcareexecutive.com2 min
OCT 7
$LWHighAI 8/10

US Stock Movers: Lamb Weston, Option Care, Apogee Rally

Lamb Weston (LW) shares rose 11.85% after reporting Q1 sales of $1.67B and raising 2027 EBITDA guidance. Option Care (OPCH) jumped 32.8% on a $5.8B take-private deal. Apogee (APOG) gained 18.7% on strong Q2 earnings and raised FY2027 outlook. Constellation (CEG) surged 14.79% after a Google nuclear deal. RPM (RPM) rose 2.5% on record Q1 results.

hdfcsky.com2 min
OCT 7
$MCKHighAI 9/10

McKesson, CD&R to Buy Option Care for $5.8B

McKesson Corp. and private equity firm Clayton, Dubilier & Rice will acquire Option Care Health Inc. for $5.8 billion, or $32.05 per share, a 37% premium. McKesson will own 49%, with CD&R as the controlling shareholder. Option Care, a major provider of home and outpatient infusion care, will retain its management team. The deal aligns with McKesson's strategy to expand specialty care services, potentially increasing its ownership over time.

briefs.co2 min